Drugs / Plasma Rich in Growth Factors
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05364515 | Dec 2021 → Feb 2024 | vulvar lichen sclerosus | Fundación Eduardo Anitua | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Plasma Rich in Growth Factors | “Plasma Rich in Growth Factors (PRGF) is a mixture of proteins and growth factors obtained from the blood of the patient.” NCT05364515 ↗ |
| Known as | PRGF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05364515 ↗ |
| Modality | Protein / enzyme biologic | “Plasma Rich in Growth Factors (PRGF) is a mixture of proteins and growth factors obtained from the blood of the patient.” NCT05364515 ↗ |
| Route | Other | “Four PRGF infiltrations (two weeks between each infiltration).” NCT05364515 ↗ |